TOP NEWS: AstraZeneca's Imfinzi Gains Priority Review From US FDA Read More
LONDON MARKET PRE-OPEN: Ocado Signs Deal In Japan; Reach Decline Slows Read More
UK BROKER RATINGS SUMMARY: Morgan Stanley Downgrades Rolls-Royce Read More
LONDON MARKET OPEN: Promising Start Amid Blue-Chip Exec Changes Read More
US Approves AstraZeneca's Calquence In Chronic Lymphocytic Leukaemia Read More
European Commission Gives Approval To AstraZeneca Diabetes Drug Read More
TOP NEWS: Astra, Merck Gets US Priority Review For Rare Genetic Drug Read More
Astra's Anifrolumab Shows Advantage Across Various Efficacy Endpoints Read More
UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance Read More
LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain Read More
TOP NEWS: AstraZeneca Reports Positive Test Results For Anaemia Drug Read More
AstraZeneca Drug Roxadustat Increases Haemoglobin Levels In Two Trials Read More
UPDATE: AstraZeneca To Present Encouraging Data From Calquence Trial Read More
AstraZeneca Steps Up China Presence With USD1 Billion Fund, R&D Centre Read More
LONDON MARKET CLOSE: Mixed End Ahead Of US Fed Interest Rate Decision Read More
UK BROKER RATINGS SUMMARY: Liberum Downgrades Next To Hold From Buy Read More
AstraZeneca To Secure Up To USD239 Million From Commercial Rights Sale Read More
LONDON BRIEFING: Next Gets Sales Boost As Weather Turns Miserable Read More
UK BROKER RATINGS SUMMARY: UBS Cuts RBS; Goldman Says Buy Prudential Read More
AstraZeneca Phase III Poseidon Trial Meets Primary Endpoint Read More
